Please login to the form below
job losses
This page shows the latest job losses news and features for those working in and with pharma, biotech and healthcare.
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Job losses will be across manufacturing and R&D divisions. Merck &Co/MSD has set another part of its ongoing cost-cutting drive in motion, announcing the closure of a plant ... in France that will result in 207 job losses across manufacturing and R&D.
Latest news
-
Amgen exits neuroscience R&D to focus on growth areas
The latter projects will be taken over by its inflammation research teams, said Amgen, with the job losses expected to hit the hardest at its R&D facilities in Cambridge, Massachusetts,
-
Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
Company says decision is not related to Brexit
-
Mereo’s shareholders back OncoMed takeover
That prompted a cull of the pipeline and big job losses, with OncoMed focusing its energies on early-stage candidates navicixizumab, etigilimab and OMP-336b11 for solid tumours, plus a fourth
-
WPP to cut 3,500 jobs in major restructuring
The company hasn't yet made clear how the plans will affect WPP Health and Wellness, which has a large number of pharma and consumer health clients, but job losses and
-
GSK and Pfizer to create combined consumer health titan
It thinks it can carve £500m off its costs by 2022, and says that some job losses are expected.
More from news
Approximately 1 fully matching, plus 71 partially matching documents found.
Latest Intelligence
-
Creating a 21st century life sciences ecosystem
Brain drain. Since Freeman became an MP in 2010 there have been thousands of job losses across the UK as a number of companies, including GSK, Novartis, AstraZeneca and most notably
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Three strategies for managing loss of exclusivity successfully
Patent losses could sink Allergan”. 1. “Drug prices to plummet in wave of expiring patents”. ... 4. It’s no wonder “loss of exclusivity (LOE)” or “the patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat
-
Three strategies for managing loss of exclusivity successfully
Patent losses could sink Allergan”. “Drug prices to plummet in wave of expiring patents”. ... patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat of job losses and falling share prices.
-
Artificial Intelligence in healthcare
However, AI is not without its critics, with concerns including job losses where human input is no longer required, or sometimes involve deeper concerns as to the ethics intrinsic to AI. ... As mentioned earlier, job losses are also a concern. Media
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
-
B2B media account director
-
Competitive salary
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- FREELANCE Associate Director - Healthcare PR - Remote or London
-
Superb Day Rate &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- AM / Senior Account Manager – Healthcare PR - London / Remote
-
Highly Competitive Salary, Bonus &Benefits
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen hands out $120m upfront for Remedy stroke drug
- Pfizer's 2021 revenue predictions soar to $82bn
- The Pharma Multi-channel Marketing Maturity Model
- Assessing the value of interim analyses in clinical trials
- BioNTech raises €290m for mRNA cancer vaccine platform
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Diversity in clinical trials: looking back at our 2021 blogs
- In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
